Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18721InvestigationalProtein Based Therapies
Certepetide: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Integrin beta-3, Neuropilin-1, and Integrin alpha-V
- Also known as
- Ac-Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys-NH2 cyclic (1→9)-disulfide · Internalized-arginylglycylaspartic acid cyclic peptide · L-Cysteinamide, N-acetyl-L-cysteinyl-L-arginylglycyl-L-α-aspartyl-L-lysylglycyl-L-prolyl-L-α-aspartyl-, cyclic (1→9)-disulfide · L-cysteine, l-cysteinyl-l-arginylglycyl-l-.alpha.-aspartyl-l-lysylglycyl-l-prolyl-l-.alpha.-aspartyl-, cyclic (1->9)-disulfide
- Code names
- CEND-1 · IRGD · LSTA-1
Resolves to
Compound
What you can answer from here — as of July 09, 2026
Which drugs share a target with Certepetide, and which of those have an active Phase 3 trial?